Avicenna Holdings Limited has been acquired by Juno Health

The shareholders of Avicenna Holdings Limited have sold the business to Juno Health.

Based in the UK, Avicenna comprises 21 pharmacies, as well as a buying group operation serving more than 1,000 independent pharmacies.

Juno Health is a UK-based company that operates a chain of pharmacy stores. The community pharmacies will be integrated into Juno’s existing chain with the buying group continuing to be run by Salim Jetha, Avicenna CEO. It will become the industry-leading buying and support group for independent pharmacies across the UK. Juno has considerable experience in the sector and the combination of Avicenna resources and expertise will support the independent pharmacy sector and improve membership benefits.

Richard Smith, Chairman at Juno Health, said: “Avicenna is a well-established business delivering clear benefits to its members. It is one of the most recognizable brands among independent pharmacists and extremely well respected.”

Oaklins Cavendish, based in the UK, advised the shareholders of Avicenna on the sale of the business to Juno Health.

Service

M&A sell-side

Parties

Talk to the deal team

Michael Jewell

Partner

London, United Kingdom
Oaklins Cavendish

View profile Get in touch

Sam Kavanagh

Director

London, United Kingdom
Oaklins Cavendish

View profile Get in touch

Rebecca McCredie

Director

London, United Kingdom
Oaklins Cavendish

View profile Get in touch

Related deals

GARAIO has been acquired by Netrics Group

Private Equity | TMT

GARAIO has been acquired by Netrics Group

Netrics Group has acquired GARAIO AG as a wholly owned subsidiary. GARAIO will continue to operate as an independent company under the umbrella of Netrics Group. With this acquisition, Netrics Group is further expanding its leading position as a provider of managed cloud and digital workplace solutions as well as consulting services.

Learn more

Aptic has received a minority investment from Sofiouest

Private Equity | Business Support Services

Aptic has received a minority investment from Sofiouest

The shareholders of Aptic have completed a primary minority LBO with Sofiouest.

Learn more

Provital GmbH has been acquired by EMERAM Capital Partners

Private Equity | Consumer & Retail

Provital GmbH has been acquired by EMERAM Capital Partners

Dr. Thomas Brandner has sold a majority stake in Provital GmbH to private equity firm EMERAM Capital Partners. The transaction secures the future development and growth opportunities of the pet food company as EMERAM Capital Partners takes on ownership and acts as its strategic partner.

Learn more